vs
GETTY REALTY CORP（GTY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
GETTY REALTY CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$57.8M vs $35.5M），GETTY REALTY CORP净利率更高（46.0% vs -304.2%，领先350.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 10.5%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 7.6%）
Getty Realty Corp是一家总部位于美国的上市房地产投资信托（REIT），主要持有、租赁并管理商业地产资产组合，核心资产涵盖便利店、加油站及配套零售物业，业务覆盖美国多个州，服务零售与能源领域的优质租户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GTY vs RXRX — 直观对比
营收规模更大
GTY
是对方的1.6倍
$35.5M
营收增速更快
RXRX
高出671.2%
10.5%
净利率更高
GTY
高出350.3%
-304.2%
两年增速更快
RXRX
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.8M | $35.5M |
| 净利润 | $26.6M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 66.1% | -304.8% |
| 净利率 | 46.0% | -304.2% |
| 营收同比 | 10.5% | 681.7% |
| 净利润同比 | 80.1% | 39.6% |
| 每股收益（稀释后） | $0.43 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTYRXRX
| Q1 26 | $57.8M | — | ||
| Q4 25 | $60.5M | $35.5M | ||
| Q3 25 | $55.6M | $5.2M | ||
| Q2 25 | $53.3M | $19.2M | ||
| Q1 25 | $52.3M | $14.7M | ||
| Q4 24 | $53.0M | $4.5M | ||
| Q3 24 | $51.5M | $26.1M | ||
| Q2 24 | $49.9M | $14.4M |
净利润GTYRXRX
| Q1 26 | $26.6M | — | ||
| Q4 25 | $27.0M | $-108.1M | ||
| Q3 25 | $23.3M | $-162.3M | ||
| Q2 25 | $14.0M | $-171.9M | ||
| Q1 25 | $14.8M | $-202.5M | ||
| Q4 24 | $22.3M | $-178.9M | ||
| Q3 24 | $15.3M | $-95.8M | ||
| Q2 24 | $16.7M | $-97.5M |
毛利率GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率GTYRXRX
| Q1 26 | 66.1% | — | ||
| Q4 25 | 67.3% | -304.8% | ||
| Q3 25 | 62.5% | -3327.6% | ||
| Q2 25 | 46.7% | -916.8% | ||
| Q1 25 | 50.5% | -1297.9% | ||
| Q4 24 | 61.6% | -4042.4% | ||
| Q3 24 | 48.9% | -377.1% | ||
| Q2 24 | 52.5% | -697.4% |
净利率GTYRXRX
| Q1 26 | 46.0% | — | ||
| Q4 25 | 44.7% | -304.2% | ||
| Q3 25 | 42.0% | -3135.3% | ||
| Q2 25 | 26.3% | -894.2% | ||
| Q1 25 | 28.3% | -1373.3% | ||
| Q4 24 | 42.1% | -3935.5% | ||
| Q3 24 | 29.8% | -367.5% | ||
| Q2 24 | 33.5% | -676.6% |
每股收益（稀释后）GTYRXRX
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.46 | $-0.17 | ||
| Q3 25 | $0.40 | $-0.36 | ||
| Q2 25 | $0.24 | $-0.41 | ||
| Q1 25 | $0.25 | $-0.50 | ||
| Q4 24 | $0.38 | $-0.56 | ||
| Q3 24 | $0.27 | $-0.34 | ||
| Q2 24 | $0.30 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | — | $1.1B |
| 总资产 | $2.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资GTYRXRX
| Q1 26 | $3.7M | — | ||
| Q4 25 | $8.4M | $743.3M | ||
| Q3 25 | $5.2M | $659.8M | ||
| Q2 25 | $7.5M | $525.1M | ||
| Q1 25 | $6.3M | $500.5M | ||
| Q4 24 | $9.5M | $594.4M | ||
| Q3 24 | $4.0M | $427.6M | ||
| Q2 24 | $4.7M | $474.3M |
总债务GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | $995.0M | $9.6M | ||
| Q3 25 | $934.6M | $11.9M | ||
| Q2 25 | $919.2M | $14.2M | ||
| Q1 25 | $901.4M | $16.4M | ||
| Q4 24 | $904.3M | $19.0M | ||
| Q3 24 | $833.9M | $20.5M | ||
| Q2 24 | $838.4M | $22.9M |
股东权益GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $982.4M | $919.1M | ||
| Q1 25 | $961.1M | $933.9M | ||
| Q4 24 | $962.1M | $1.0B | ||
| Q3 24 | $963.4M | $524.6M | ||
| Q2 24 | $951.0M | $584.4M |
总资产GTYRXRX
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $1.9B | $726.5M | ||
| Q2 24 | $1.9B | $775.9M |
负债/权益比GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | 0.93× | 0.01× | ||
| Q3 25 | 0.92× | 0.01× | ||
| Q2 25 | 0.94× | 0.02× | ||
| Q1 25 | 0.94× | 0.02× | ||
| Q4 24 | 0.94× | 0.02× | ||
| Q3 24 | 0.87× | 0.04× | ||
| Q2 24 | 0.88× | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | $127.4M | $-46.1M | ||
| Q3 25 | $30.5M | $-117.4M | ||
| Q2 25 | $34.7M | $-76.4M | ||
| Q1 25 | $28.7M | $-132.0M | ||
| Q4 24 | $130.5M | $-115.4M | ||
| Q3 24 | $34.6M | $-59.2M | ||
| Q2 24 | $29.7M | $-82.2M |
自由现金流GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | $127.0M | $-47.3M | ||
| Q3 25 | $30.4M | $-117.6M | ||
| Q2 25 | $34.6M | $-79.6M | ||
| Q1 25 | $28.6M | $-133.8M | ||
| Q4 24 | $129.6M | $-116.7M | ||
| Q3 24 | $34.4M | $-63.8M | ||
| Q2 24 | $29.6M | $-83.4M |
自由现金流率GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | 209.8% | -133.1% | ||
| Q3 25 | 54.7% | -2272.5% | ||
| Q2 25 | 64.9% | -413.9% | ||
| Q1 25 | 54.7% | -907.4% | ||
| Q4 24 | 244.5% | -2567.7% | ||
| Q3 24 | 66.9% | -244.6% | ||
| Q2 24 | 59.2% | -578.5% |
资本支出强度GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 3.5% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.3% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 1.7% | 28.6% | ||
| Q3 24 | 0.4% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% |
现金转化率GTYRXRX
| Q1 26 | — | — | ||
| Q4 25 | 4.71× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 1.94× | — | ||
| Q4 24 | 5.85× | — | ||
| Q3 24 | 2.26× | — | ||
| Q2 24 | 1.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
